Cargando…

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Reduces Oxidative and Mechanical Stress-Evoked Matrix Degradation in Chondrifying Cell Cultures

Pituitary adenylate cyclase activating polypeptide (PACAP) is an endogenous neuropeptide also secreted by non-neural cells, including chondrocytes. PACAP signaling is involved in the regulation of chondrogenesis, but little is known about its connection to matrix turnover during cartilage formation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szentléleky, Eszter, Szegeczki, Vince, Karanyicz, Edina, Hajdú, Tibor, Tamás, Andrea, Tóth, Gábor, Zákány, Róza, Reglődi, Dóra, Juhász, Tamás
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337298/ https://www.ncbi.nlm.nih.gov/pubmed/30621194 http://dx.doi.org/10.3390/ijms20010168

Ejemplares similares

Lack of Pituitary Adenylate Cyclase–Activating Polypeptide (PACAP) Disturbs Callus Formation
por: Józsa, Gergő, et al.
Publicado: (2019)

Signalling Alterations in Bones of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Gene Deficient Mice
por: Józsa, Gergő, et al.
Publicado: (2018)

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Pathway Is Induced by Mechanical Load and Reduces the Activity of Hedgehog Signaling in Chondrogenic Micromass Cell Cultures
por: Juhász, Tamás, et al.
Publicado: (2015)

Age-related alterations of articular cartilage in pituitary adenylate cyclase–activating polypeptide (PACAP) gene–deficient mice
por: Szegeczki, Vince, et al.
Publicado: (2019)

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Signalling Exerts Chondrogenesis Promoting and Protecting Effects: Implication of Calcineurin as a Downstream Target
por: Juhász, Tamás, et al.
Publicado: (2014)

Physical Activity Protects the Pathological Alterations of Alzheimer’s Disease Kidneys via the Activation of PACAP and BMP Signaling Pathways
por: Perényi, Helga, et al.
Publicado: (2020)

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells
por: Kasica, Natalia, et al.
Publicado: (2016)

Hearing impairment and associated morphological changes in pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice
por: Fulop, Daniel Balazs, et al.
Publicado: (2019)

Pituitary Adenylate Cyclase Activating Polypeptide Has Inhibitory Effects on Melanoma Cell Proliferation and Migration In Vitro
por: Hajdú, Tibor, et al.
Publicado: (2021)

Intestinal Microbiota Changes in Mice Lacking Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) – Bifidobacteria Make the Difference
por: Heimesaat, Markus M., et al.
Publicado: (2017)

The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Is Protective in Inflammation and Oxidative Stress-Induced Damage in the Kidney
por: Horvath, Gabriella, et al.
Publicado: (2019)

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation
por: Tóth, Dénes, et al.
Publicado: (2023)

Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models
por: Maasz, Gabor, et al.
Publicado: (2017)

Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death
por: Horvath, Gabriella, et al.
Publicado: (2022)

Presence and Effects of Pituitary Adenylate Cyclase Activating Polypeptide Under Physiological and Pathological Conditions in the Stomach
por: Reglodi, Dora, et al.
Publicado: (2018)

Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
por: Cardoso, João C. R., et al.
Publicado: (2020)

Alzheimer’s Disease Mouse as a Model of Testis Degeneration
por: Szegeczki, Vince, et al.
Publicado: (2020)

Editorial: Novel Therapeutic Potential for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), Vasoactive Intestinal Peptide (VIP) and Related Peptides in Cognition Deficits
por: Ciranna, Lucia, et al.
Publicado: (2021)

Corrigendum: Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
por: Cardoso, João C. R., et al.
Publicado: (2020)

Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraine
por: Ashina, Messoud
Publicado: (2022)

Physical Training Inhibits the Fibrosis Formation in Alzheimer’s Disease Kidney Influencing the TGFβ Signaling Pathways
por: Szegeczki, Vince, et al.
Publicado: (2021)

Pituitary adenylate cyclase-activating polypeptide (PACAP) in zebrafish models of nephrotic syndrome
por: Eneman, Benedicte, et al.
Publicado: (2017)

Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma
por: Patko, Evelin, et al.
Publicado: (2023)

Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
por: Atlasz, Tamas, et al.
Publicado: (2018)

Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice
por: Hattori, Satoko, et al.
Publicado: (2012)

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus
por: Johnson, Gregory C., et al.
Publicado: (2020)

Examination of pituitary adenylate cyclase-activating polypeptide in Parkinson’s disease focusing on correlations with motor symptoms
por: Pham, Daniel, et al.
Publicado: (2022)

Protective Effects of PACAP in Peripheral Organs
por: Toth, Denes, et al.
Publicado: (2020)

Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
por: Ashina, Messoud, et al.
Publicado: (2018)

Pituitary adenylate cyclase-activating polypeptide (PACAP) acts in the nucleus accumbens to reduce hedonic drive
por: Hurley, Matthew M., et al.
Publicado: (2018)

Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model
por: Botz, Bálint, et al.
Publicado: (2014)

Pituitary Adenylate Cyclase-Activating Polypeptide Ameliorates Experimental Acute Ileitis and Extra-Intestinal Sequelae
por: Heimesaat, Markus M., et al.
Publicado: (2014)

SUN-484 Effect of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in the Regulation of Hypothalamic Kisspeptin Expression
por: Kanasaki, Haruhiko, et al.
Publicado: (2019)

Relationship between Plasma Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Level and Proteome Profile of Cows
por: Czegledi, Levente, et al.
Publicado: (2022)

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis
por: Christensen, Casper Emil, et al.
Publicado: (2022)

Stability Test of PACAP in Eye Drops
por: Kovacs, Anita K., et al.
Publicado: (2020)

Immunomodulatory Effects of the Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide in Acute Toxoplasmosis
por: Figueiredo, Caio Andreeta, et al.
Publicado: (2019)

Pituitary adenylate cyclase-activating polypeptide (PACAP) contributes to the proliferation of hematopoietic progenitor cells in murine bone marrow via PACAP-specific receptor
por: Xu, Zhifang, et al.
Publicado: (2016)

Pituitary Adenylate Cyclase-Activating Polypeptide Alleviates Intestinal, Extra-Intestinal and Systemic Inflammatory Responses during Acute Campylobacter jejuni-induced Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Pituitary Adenylate Cyclase-Activating Polypeptide—A Neuropeptide as Novel Treatment Option for Subacute Ileitis in Mice Harboring a Human Gut Microbiota
por: Bereswill, Stefan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5pkep3qfoib8gbq5pqvcku29q5